Evidence map›Paper›PMID 21368211›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Design and control of acetylcholine receptor conformational change.

Snehal V Jadey, Prasad Purohit, Iva Bruhova, Timothy M Gregg, Anthony Auerbach

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 52 citations in OpenAlex.

  1. Positive allosteric modulator selective for adult muscle nicotinic acetylcholine receptor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pathways for nicotinic receptor desensitization.The Journal of general physiology · 2020
    Article
  8. Article
  9. Article
  10. Cyclic activation of endplate acetylcholine receptors.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Functional differences between neurotransmitter binding sites of muscle acetylcholine receptors.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Snehal V JadeyDepartment of Physiology and Biophysics, 309 Cary Hall, State University of New York, Buffalo, NY 14214, USA.
Prasad Purohit
Iva Bruhova
Timothy M Gregg
Anthony Auerbach
University at Buffalo, State University of New York · USCanisius College · US

Funding

MULTIPLE ACTIVITY PATTERNS OF ACETYLCHOLINE RECEPTORSR37NS023513 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 2000 to 2013
$6.9M
Engineering a Transmitter Binding SiteR01NS064969 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 2009 to 2018
$4.1M
MULTIPLE ACTIVITY PATTERNS OF ACETYLCHOLINE RECEPTORSR01NS023513 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 1987 to 1999
–
NINDS NIH HHS NS 064969NINDS NIH HHS NS 23513NINDS NIH HHS R01 NS064969NINDS NIH HHS R37 NS023513
6 · The paper itself

Abstract

Allosteric proteins use energy derived from ligand binding to promote a global change in conformation. The "gating" equilibrium constant of acetylcholine receptor-channels (AChRs) is influenced by ligands, mutations, and membrane voltage. We engineered AChRs to have specific values of this constant by combining these perturbations, and then calculated the corresponding values for a reference condition. AChRs were designed to have specific rate and equilibrium constants simply by adding multiple, energetically independent mutations with known effects on gating. Mutations and depolarization (to remove channel block) changed the diliganded gating equilibrium constant only by changing the unliganded gating equilibrium constant (E(0)) and did not alter the energy from ligand binding. All of the tested perturbations were approximately energetically independent. We conclude that naturally occurring mutations mainly adjust E(0) and cause human disease because they generate AChRs that have physiologically inappropriate values of this constant. The results suggest that the energy associated with a structural change of a side chain in the gating isomerization is dissipated locally and is mainly independent of rigid body or normal mode motions of the protein. Gating rate and equilibrium constants are estimated for seven different AChR agonists using a stepwise engineering approach.

Indexed as

AcetylcholineAnimalsCalibrationCholinergic AgonistsHEK293 CellsHumansIon Channel GatingKineticsMiceMutant ProteinsMutationProtein Structure, SecondaryPyrrolidinesReceptors, CholinergicAcetylcholineCholinergic AgonistsMutant ProteinsPyrrolidinesReceptors, Cholinergic

Identifiers

PMID21368211
PMCPMC3060238
OpenAlexW2003993752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.